Huawei's Cutting-Edge Digitalization Solution Promises Accelerated Intelligence in Medical Technology...
The US Food and Drug Administration (FDA) approval in December 2023, of two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of a rare disease called sickle cell disease (SCD) in patients 12 years and older, is a huge development. With rare diseases posing significant challenges due to the scarcity of information, limited research, and insufficient awareness among healthcare professionals and the public, introduction and approval of s...
Siriraj Hospital's Commitment to Comprehensive Cancer Care...
Tucson Medical Center Implants First Patient with Novel Investigational Device...
First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing...
First-ever installation in Fortis Hospital, Bengaluru...
American Lung Association releases report detailing health benefits for children of transition to zero-emission vehicles and electricity...
GALI™ SonR® CRT-D and NAVIGO™ 4LV Pacing Leads Launch Set to Enhance Heart Failure Management and Patient Safety...
Establishing a comprehensive "AI-assisted Physician" using generative AI from Google Cloud, including MedLM...
Supporting Employee Well-Being: Boston Scientific's Mental Health Benefits...
